Lung cancer staging and treatment

Doctors assess the primary tumour, nearby lymph nodes, and distant spread. This produces a stage that helps the team judge whether local treatment, whole-body treatment, symptom-focused care, or a combination makes sense. The cancer subtype and genomic features may alter the plan even when two people share a stage.

Treatment aims can differ: removing visible disease, reducing the chance of return, controlling cancer that cannot be removed, easing symptoms, or preserving function. Those aims should be stated plainly so you know what each treatment is intended to do.

Bring a list of medicines, existing conditions, breathing limitations, and priorities for work or family life. Ask whether tissue diagnosis and genomic tumour profiling are complete. Depending on the findings, options may include lung lobectomy, radiotherapy, chemotherapy, or other systemic treatment. A second opinion can be reasonable when the proposed operation, sequence, or treatment aim is unclear.

Call the care team promptly for worsening breathlessness, fever during treatment, chest pain, coughing blood, dehydration, or new confusion. Seek emergency help for severe breathing difficulty, blue lips, fainting, sudden weakness, or a sudden change in speech. Persistent hoarseness should be assessed, but it does not by itself identify the cause.

What is the stage and cancer subtype? What is the goal of each proposed treatment? Why is this sequence recommended? What side effects should be reported immediately? Would genomic profiling or a second opinion change the options?